Ground-breaking research published in the journal Nature has utilised a precise gene-editing technique, known as adenine base editing, to uncover the critical role of a specific gene, NANOG, in the very early stages of human embryo development. The study provides fundamental insights into how human embryos form the initial cells that will eventually become the fetus, placenta, and yolk sac.
Dr Helen O’Neill, Associate Professor of Reproductive and Molecular Genetics at University College London (UCL), emphasised that the research focuses on understanding basic biological processes, rather than creating 'gene-edited babies'. The team specifically targeted NANOG, a gene previously identified in stem cell and animal studies as central to pluripotency – the ability of stem cells to differentiate into any cell type. The most striking finding was that when NANOG was disrupted in human embryos, the epiblast, the cell population destined to form the embryo itself, failed to develop normally. Interestingly, the human embryos still retained primitive endoderm-like cells, a response that differs from what is observed in mouse embryos, underscoring that human development cannot simply be inferred from animal models.
The value of genome editing in human embryos, as highlighted by Dr O'Neill, is multifaceted. Firstly, it allows scientists to decipher the genetic rules governing the earliest stages of human life. Secondly, it could provide crucial understanding into why a significant number of embryos fail during IVF, despite appearing healthy. Thirdly, in the long term, this research might offer new perspectives for a small group of patients with serious inherited conditions for whom existing preimplantation genetic testing is insufficient.
Professor Robin Lovell-Badge FRS FMedSci, a Group Leader at the Francis Crick Institute, echoed the importance of this foundational knowledge. He noted that approximately 70% of fertilised eggs fail to result in a healthy baby. Greater understanding of early human embryo development, he argues, will increase the chances of reducing distress, disappointment, and debilitating disorders. The research, conducted by Oliver Bower and others associated with Kathy Niakan’s laboratory, exemplifies best practice in research while yielding new knowledge about the first week of human development.
The researchers involved maintain a cautious approach. The number of embryos studied was small, and none were transferred. There remain unresolved questions regarding mosaicism (where an individual has cells with different genetic makeups), off-target effects (unintended genetic changes), and developmental competence. However, base editing appears to be a less disruptive method for studying gene function in embryos compared to older CRISPR techniques that create double-strand DNA breaks.
This study is considered a significant basic science advance, not a clinical green light. It reinforces the argument for carefully regulated human embryo research, demonstrating that direct study of human embryos can reveal biological insights that animal models cannot fully capture. Such research is vital for improving IVF outcomes, enhancing embryo selection, and providing more informed options for patients facing inherited diseases.